Johnson & Johnson: In Talks To Resolve US Probe Of Risperdal Marketing

Wall Street Journal -- Johnson & Johnson (JNJ) said it's in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal.